2024 Tumor Board Tuesday Evaluation Evaluation In order to receive a CME certificate for your participation in this activity, please complete this survey in its entirety. Please allow 4 weeks for your certificate to be processed. Question Title * 1. What is your degree? MD/DO NP PA Pharmacist Nurse Other (please specify) Question Title * 2. What is your specialty? Med/Surg/Rad/IR Onc Other MD, APP, RN, PharmD Patient/Patient Advocate Fellow, Resident, Trainee Question Title * 3. How many years have you been in practice? >21 11-20 1-10 <1 Question Title * 4. How many patients with advanced or metastatic cancers do you treat each week? 1 to 10 11 to 25 26 to 50 I am not directly involved in patient care Question Title * 5. Please select the option that best describes your practice: Academic Clinician Community Clinician Other (please specify) Question Title * 6. The content presented:4 = Strongly agree, 3 = Agree, 2 = Disagree, 1 = Strongly disagree Strongly agree Agree Disagree Strongly disagree Enhanced my current knowledge base Enhanced my current knowledge base Strongly agree Enhanced my current knowledge base Agree Enhanced my current knowledge base Disagree Enhanced my current knowledge base Strongly disagree Addressed my most pressing questions Addressed my most pressing questions Strongly agree Addressed my most pressing questions Agree Addressed my most pressing questions Disagree Addressed my most pressing questions Strongly disagree Promoted improvements or quality in health care Promoted improvements or quality in health care Strongly agree Promoted improvements or quality in health care Agree Promoted improvements or quality in health care Disagree Promoted improvements or quality in health care Strongly disagree Was scientifically rigorous and evidence based Was scientifically rigorous and evidence based Strongly agree Was scientifically rigorous and evidence based Agree Was scientifically rigorous and evidence based Disagree Was scientifically rigorous and evidence based Strongly disagree Question Title * 7. These activities were free from commercial bias. Yes No (please explain) Question Title * 8. Which new strategies/skills/information will you apply to your area of practice? Select all that apply Be better at understanding molecular alterations in advanced or metastatic cancers and their impact on therapeutic decision making. Be better able to utilize best practices when transitioning therapies. Elucidate the genomic, immunogenic, and proteomic aberrations that serve as molecular drivers for a wide variety of solid tumors. Mandate the necessity for a personalized approach to treatment when dealing with solid tumors. Select personalized treatments for patients with breast, gastrointestinal, genitourinary, and lung cancer based on the characteristics of each patient and the molecular profile of each tumor. Assess treatments currently in late-phase development that are being studied for their ability to address actionable molecular targets common to disease state subsets within breast, gastrointestinal, genitourinary, and lung cancers. Integrate strategies to monitor and proactively plan to mitigate treatment related side effects Question Title * 9. How committed are you to making changes in your practice based on your participation in these activities? Very Committed Committed Neutral Not committed I do not plan to make changes Question Title * 10. As a result of your participation in these activities, what is the one change you are most likely to implement in your practice? Question Title * 11. What barriers do you see to making changes in your practice? Select all that apply. Lack of knowledge regarding evidence-based strategies Lack of convincing evidence to warrant change Lack of time/resource to consider change Insurance, reimbursement, or legal issues Conflicting guidelines and/or evidence Patient compliance and/or patient resource barriers Other (please specify) Question Title * 12. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities: Next